Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Loss-of-control Eating: early-phase trial registry

1 of 4 indexed Loss-of-control Eating trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Loss-of-control Eating: 4 US clinical trials tracked, 1 recruiting.

Loss-of-control Eating is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 3 of these trials.

Enrollment posture brief

Registry condition loss-of-control-eating

OPEN 1 | RECR 25% | LATE 0 | EARLY 3 | RANK #4115 | SPON 3

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Loss-of-control Eating (this)25%
Open-enrollment share among volume-matched conditions near Loss-of-control Eating

Loss-of-control Eating lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Loss-of-control Eating on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Loss-of-control Eating is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 23

Phase Distribution

PhaseTrial count
Phase 2 3

Top Sponsors

Named interventions

Most-linked intervention names on Loss-of-control Eating records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
3 trials
Lisdexamfetamine Dimesylate (Medication) Drug
1 trials
Naltrexone and Bupropion (NB) medication Drug
1 trials
responsive neurostimulation Device
1 trials
Behavioral Weight Loss Behavioral
1 trials
Naltrexone and Bupropion medication Drug
1 trials

US sites by state

Facility locations filed on Loss-of-control Eating trials. A trial with sites in several states counts in each.

Connecticut 3 trials
Pennsylvania 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Loss-of-control Eating page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Loss-of-control Eating trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Yale University sponsors the most Loss-of-control Eating trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Loss-of-control Eating condition card totals 4 registered trials; most-linked intervention Placebo; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.